Novel Differentiation Therapies for AML and Prognostic Value of PET in MM
Dr. Laurie Sehn interviews Drs. Vijay Sankaran, Ruud Delwel, and Françoise Kraeber-Bodere about novel differentiation therapies for AML targeting the MECOM gene and the prognostic significance of PET scan results in MM patients from the CASSIOPET study.